Transfusion of intra-operative autologous whole blood: Influence on complement activation and interleukin formation

Vox Sanguinis

Volumn 100, Issue 2, 2011, Pages 239-246

  Stachura, A ^a   Krol R ^a   Poplawski, T ^a   Michalik, D ^b   Pomianowski, S ^b   Jacobsson, M ^c   Aberg M ^c   Bengtsson, A ^c  

^a Im Prof Alfreda Sokolowskiego ^*  (Poland)

^b Leczenia Oparzen i Chir Plastycznej   (Poland)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Autologous whole blood; Clinical trial; Complement activation; Intra operative blood salvage; Pro inflammatory cytokines

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3A; CREATININE; CYTOKINE; D DIMER; ELASTASE; HEMOGLOBIN; INTERLEUKIN 6; INTERLEUKIN 8; POTASSIUM; POTASSIUM ION; SODIUM ION;

AGED; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLEMENT ACTIVATION; ERYTHROCYTE VOLUME; FEMALE; HIP ARTHROPLASTY; HUMAN; LEUKOCYTE; MALE; MULTICENTER STUDY; OPEN STUDY; PARTIAL THROMBOPLASTIN TIME; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; SAFETY;

AGED; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD TRANSFUSION, AUTOLOGOUS; COMPLEMENT ACTIVATION; FEMALE; HUMANS; INTERLEUKINS; INTRAOPERATIVE CARE; MALE; MONITORING, PHYSIOLOGIC; OPERATIVE BLOOD SALVAGE;

EID: 78651339576     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2010.01377.x     Document Type: Article

References (27)

1. Gilstad CW: Anaphylactic transfusion reactions. Curr Opin Hematol 2003; 10:419-423
2. Bux J: Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion. Vox Sang 2005; 89:1-10
3. Blajchman MA: Immunomodulation and blood transfusion. Am J Ther 2002; 9:389-395
4. Goodnough LT: Risks of blood transfusion. Anesthesiol Clin North America 2005; 23:241-252
5. Rees JE, Jeavons R, Dixon JH: An economic justification for autologous blood re-infusion in primary total knee replacement surgery. Ann R Coll Surg Engl 2005; 87:102-105
6. Marcucci C, Madjdpour C, Spahn DR: Allogeneic blood transfusions: benefit, risks and clinical indications in countries with a low or high human development index. Br Med Bull 2004; 70:15-28
7. Waters JH: Indications and contraindications of cell salvage. Transfusion 2004; 44:40-44
8. Shiga T, Wajima Z, Inoue T, et al. Aprotinin in major orthopedic surgery: a systematic review of randomized controlled trials. Anesth Analg 2005; 101:1602-1607
9. Dixon S, James V, Hind D, et al. Economic analysis of the implementation of autologous transfusion technologies throughout England. Int J Technol Assess Health Care 2005; 21:234-239
10. Benoni G, Fredin H, Knebel R, et al. Blood conservation with tranexamic acid in total hip arthroplasty: a randomized, double-blind study in 40 primary operations. Acta Orthop Scand 2001; 72:442-448
11. Albala DM: Fibrin sealants in clinical practice. Cardiovasc Surg 2003; 11:5-11
12. Bengtsson A, Bengtson JP: Autologous blood transfusion: preoperative blood collection and blood salvage techniques. Acta Anaesthesiol Scand 1996; 40:1041-1056
13. Muñoz M, Cobos A, Campos A, et al. Impact of postoperative shed blood transfusion, with or without leucocyte reduction, on acute-phase response to surgery for total knee replacement. Acta Anaesthesiol Scand 2005; 49:1182-1190
14. Sinardi D, Marino A, Chillemi S, et al. Composition of the blood sampled from surgical drainage after joint arthroplasty: quality of return. Transfusion 2005; 45:202-207
15. Riou B, Arock M, Guerrero M, et al. Haematological effects of postoperative autotransfusion in spinal surgery. Acta Anaesthesiol Scand 1994; 38:336-341
16. Krohn CD, Reikerås O, Bjørnsen S, et al. Fibrinogen, fibrin and its degradation products in drained blood after major orthopaedic surgery. Blood Coagul Fibrinolysis 1999; 10:167-171
17. Duchow J, Ames M, Hess T, et al. Activation of plasma coagulation for unwashed drainage blood after hip joint arthroplasty. J Arthroplasty 2001; 16:844-849
18. Andersson I, Tylman M, Bengtson JP, et al. Complement split products and proinflammatory cytokines in salvaged blood after hip and knee arthroplasty. Can J Anaesth 2001; 48:251-255
19. Gharehbaghian A, Haque KM, Truman C, et al. Effect of autologous salvaged blood on postoperative natural killer cell precursor frequency. Lancet 2004; 363:1025-1030
20. Horstmann WG, Ettema HB, Verheyen CC: Dutch orthopedic blood management urveys 2002 and 2007: an increasing use of blood-saving measures. Arch Orthop Trauma Surg. 2010; 130:55-59
21. Åvall A, Hyllner M, Bengtson JP, et al. Greater increase in cytokine concentrations after salvage with filtered whole blood than with washed red cells, but no difference in postoperative haemoglobin recovery. Transfusion 1999; 39:271-276
22. Minetto MA, Oprandi G, Saba L, et al. Serum interleukin-6 response to elective total hip replacement surgery. Int Orthop 2006; 30:172-176
23. Åvall A, Hyllner M, Bengtson JP, et al. Postoperative inflammatory response after autologous and allogenic blood transfusion. Anesthesiology 1997; 87:511-516
24. Hyllner M, Arnestad JP, Bengtson JP, et al. Complement activation during storage of whole blood, red cells, plasma, and buffy coat. Transfusion 1997; 37:264-268
25. Perttilä J, Leino L, Pöyhönen M, et al. Leukocyte content in blood processed by autotransfusion devices during open-heart surgery. Acta Anaesthesiol Scand 1995; 39:445-448
26. Melo A, Serrick CJ, Scholz M, et al. Quality of red blood cells using the Dideco Electa autotransfusion device. J Extra Corpor Technol. 2005; 37:58-59
27. Kvarnström A, Schmidt A, Tylman M, et al. Complement split products and proinflammatory cytokines in intraoperatively salvaged unwashed blood during hip replacement: comparison between heparin-coated and non-heparin-coated autotransfusion systems. Vox Sang 2008; 9:33-38